iBstone AuraLink vs RxEars Rxi

The iBstone AuraLink is a mid-priced OTC hearing aid released in 2024, earning a B grade with a SoundScore of 3.6/5 in our lab testing. At $649, it ranks #33 of 65 OTC hearing aids tested, placing it in the top 49% of its category. This behind-the-ear device demonstrates a distinctive performance profile with notable strengths in specific areas. Music streaming stands out as a clear highlight, scoring 3.6/5—a solid result that lands 1.68 points above the OTC category average. Feedback handling is excellent at 5.0/5, exceeding the already-high category average by 0.46 points. Own-voice comfort scores 2.7/5, slightly above the category average but only mixed in absolute terms. The AuraLink's limitations appear in speech clarity metrics. Speech in quiet scores 2.3/5, falling 0.47 points below the category average—a mixed result that may affect conversational understanding in calm environments. Speech in noise presents a more significant challenge at 1.0/5, which is 0.48 points below the category average and low in absolute terms. This hearing aid may appeal most to users who prioritize music listening and phone streaming over speech clarity in challenging environments. However, budget-conscious shoppers should note that alternatives like the iHear MatriX offer higher scores at lower prices. The AuraLink's strength in feedback stability and streaming audio quality represents a specific value proposition for users whose priorities align with these capabilities.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it ranks #24 of 39 prescription hearing aids tested, placing it in the top 59% of its category. This device demonstrates notable strengths in speech understanding in quiet environments, scoring 4.3/5—a strong result that sits 0.89 points above the category average of 3.40/5. Feedback handling is excellent at 4.7/5, providing stable performance during movement without the whistling that can plague some hearing aids. Speech in noise performance is mixed at 2.1/5, essentially matching the category average. The RxEars Rxi has significant limitations to consider. Own-voice comfort scores low at 1.6/5, falling 1.10 points below the category average—users may notice their own voice sounds unnatural or boomy. Music streaming is not supported, scoring 0.0/5, which is 2.76 points below the category average. This device uses disposable batteries rather than rechargeables. The RxEars Rxi is best suited for users who prioritize discreet cosmetics and clear speech understanding in quieter settings, and who don't need music streaming capabilities. Those sensitive to own-voice quality or who frequently listen to streamed audio should explore alternatives.